Original language | English (US) |
---|---|
Article number | 79 |
Journal | Blood cancer journal |
Volume | 12 |
Issue number | 5 |
DOIs | |
State | Published - May 2022 |
ASJC Scopus subject areas
- Hematology
- Oncology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Blood cancer journal, Vol. 12, No. 5, 79, 05.2022.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia
T2 - a CRuCIAL study
AU - García-Martín, Paloma
AU - Díez, Ana Moñiz
AU - Maldonado, José Manuel Sánchez
AU - Serrano, Antonio José Cabrera
AU - ter Horst, Rob
AU - Benavente, Yolanda
AU - Landi, Stefano
AU - Macauda, Angelica
AU - Clay-Gilmour, Alyssa
AU - Hernández-Mohedo, Francisca
AU - Niazi, Yasmeen
AU - González-Sierra, Pedro
AU - Espinet, Blanca
AU - Rodríguez-Sevilla, Juan José
AU - Maffei, Rossana
AU - Blanco, Gonzalo
AU - Giaccherini, Matteo
AU - Puiggros, Anna
AU - Cerhan, James
AU - Marasca, Roberto
AU - Cañadas-Garre, Marisa
AU - López-Nevot, Miguel Ángel
AU - Chen-Liang, Tzu
AU - Thomsen, Hauke
AU - Gámez, Irene
AU - Moreno, Víctor
AU - Marcos-Gragera, Rafael
AU - García-Álvarez, María
AU - Llorca, Javier
AU - Jerez, Andrés
AU - Berndt, Sonja
AU - Butrym, Aleksandra
AU - Norman, Aaron D.
AU - Casabonne, Delphine
AU - Luppi, Mario
AU - Slager, Susan L.
AU - Hemminki, Kari
AU - Li, Yang
AU - Alcoceba, Miguel
AU - Campa, Daniele
AU - Canzian, Federico
AU - de Sanjosé, Silvia
AU - Försti, Asta
AU - Netea, Mihai G.
AU - Jurado, Manuel
AU - Sainz, Juan
N1 - Funding Information: This work was partially supported by the European Union’s Horizon 2020 research and innovation program (grant No 856620); grants from the Instituto de Salud Carlos III (Madrid, Spain; PI17/02256 and PI20/01845); Consejería de Economía, Conocimiento, Empresas y Universidad (Granada, Spain; A-CTS-448-UGR18); Consejería de Transformación Económica, Industria, Conocimiento y Universidades (Sevilla, Spain; PY20/01282); Generalitat de Catalunya (17SGR437); Gilead Sciences Fellowship (GLD17/00282); the “Xarxa de Bancs de tumors“ sponsored by Pla Director d’Oncologia de Catalunya (XBTC); the Associazione Italiana per la Ricerca sul Cancro and Fondazione Cariplo (TRIDEO 16923 and AIRC IG21436); the Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE; and the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PY - 2022/5
Y1 - 2022/5
UR - http://www.scopus.com/inward/record.url?scp=85130175544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130175544&partnerID=8YFLogxK
U2 - 10.1038/s41408-022-00676-8
DO - 10.1038/s41408-022-00676-8
M3 - Letter
C2 - 35581176
AN - SCOPUS:85130175544
SN - 2044-5385
VL - 12
JO - Blood cancer journal
JF - Blood cancer journal
IS - 5
M1 - 79
ER -